Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 10-Apr-24 4:30 PM View:  | Henderson Molly CFO and CBO | Phathom Pharmaceuticals, Inc. (PHAT) | 08-Apr-24 | Sale | 3,435 | $11.10 | $38,128.50 | (3%) 100.61K to 97.17K | |
| 26-Mar-24 4:05 PM View: | Curran Terrie President and Chief Executive Director | Phathom Pharmaceuticals, Inc. (PHAT) | 22-Mar-24 | Sale | 16,851 | $9.11 | $153,513.00 | (4%) 431.48K to 414.62K | |
| 25-Jan-24 6:13 AM View: | Takeda Pharmaceutical Co Ltd 10% Owner | Phathom Pharmaceuticals, Inc. (PHAT) | 24-Jan-24 | Sale | 3,703,700 | $8.10 | $30,000,000.00 | (50%) 7.46M to 3.76M | |
| 22-Jan-24 8:22 PM View: | Henderson Molly CFO and CBO | Phathom Pharmaceuticals, Inc. (PHAT) | 19-Jan-24 | Sale | 6,307 | $7.75 | $48,900.10 | (6%) 106.92K to 100.61K | |
| 21-Nov-23 4:40 PM View: | Henderson Molly CFO and CBO | Phathom Pharmaceuticals, Inc. (PHAT) | 20-Nov-23 | Sale | 2,127 | $7.24 | $15,402.70 | (2%) 106.32K to 104.19K | |
| 08-Nov-23 7:56 PM View: | Parikh Asit Director | Phathom Pharmaceuticals, Inc. (PHAT) | 08-Nov-23 | Purchase | 2,500 | $7.80 | $19,500.00 | 5% 52.5K to 55.0K | |
| 08-Nov-23 7:56 PM View: | Parikh Asit Director | Phathom Pharmaceuticals, Inc. (PHAT) | 07-Nov-23 | Purchase | 4,000 | $7.76 | $31,040.00 | 8% 48.5K to 52.5K | |
| 08-Nov-23 7:56 PM View: | Parikh Asit Director | Phathom Pharmaceuticals, Inc. (PHAT) | 06-Nov-23 | Private Purchase | 1,000 | $8.04 | $8,040.00 | 2% 47.5K to 48.5K | |
| 03-Nov-23 4:55 PM View: | Henderson Molly CFO and CBO | Phathom Pharmaceuticals, Inc. (PHAT) | 01-Nov-23 | Sale | 12,492 | $8.88 | $110,871.00 | (11%) 118.81K to 106.32K | |
| 03-Nov-23 4:54 PM View: | Nabulsi Azmi Chief Operating Officer | Phathom Pharmaceuticals, Inc. (PHAT) | 01-Nov-23 | Grant | 32,500 | -- | -- | 3% 998.85K to 1.03M | |
| 03-Nov-23 4:53 PM View: | Curran Terrie President and Chief Executive Director | Phathom Pharmaceuticals, Inc. (PHAT) | 01-Nov-23 | Grant | 37,500 | -- | -- | 10% 393.25K to 430.75K | |
| 03-Nov-23 4:55 PM View: | Henderson Molly CFO and CBO | Phathom Pharmaceuticals, Inc. (PHAT) | 01-Nov-23 | Grant | 22,500 | -- | -- | 23% 96.31K to 118.81K | |
| 17-Jul-23 5:00 PM View: | Nabulsi Azmi Chief Operating Officer | Phathom Pharmaceuticals, Inc. (PHAT) | 14-Jul-23 | Grant | 110,000 | -- | -- | 12% 888.85K to 998.85K | |
| 17-Jul-23 5:00 PM View: | Curran Terrie President and Chief Executive Director | Phathom Pharmaceuticals, Inc. (PHAT) | 14-Jul-23 | Grant | 200,000 | -- | -- | 103% 193.25K to 393.25K | |
| 17-Jul-23 5:00 PM View: | Henderson Molly CFO and CBO | Phathom Pharmaceuticals, Inc. (PHAT) | 14-Jul-23 | Grant | 25,000 | $1.00 | $25,000.00 | 35% 71.31K to 96.31K | |
| 05-Jun-23 6:37 PM View: | Parikh Asit Director | Phathom Pharmaceuticals, Inc. (PHAT) | 02-Jun-23 | Grant | 15,000 | $7.40 | $111,000.00 | 46% 32.5K to 47.5K | |
| 05-Jun-23 6:32 PM View: | Henderson Molly CFO and CBO | Phathom Pharmaceuticals, Inc. (PHAT) | 02-Jun-23 | Sale (Planned) | 1,960 | $11.41 | $22,367.70 | (3%) 70.81K to 68.84K | |
| 30-May-23 6:46 PM View: | Cola Michael F Director | Phathom Pharmaceuticals, Inc. (PHAT) | 25-May-23 | Grant | 9,000 | -- | -- | 92% 9.8K to 18.8K | |
| 30-May-23 6:53 PM View: | Kunz Heidi Director | Phathom Pharmaceuticals, Inc. (PHAT) | 25-May-23 | Grant | 9,000 | -- | -- | 100% 0 to 9.0K | |
| 30-May-23 6:57 PM View: | Socks David A Director | Phathom Pharmaceuticals, Inc. (PHAT) | 25-May-23 | Grant | 9,000 | -- | -- | < 1% 1.21M to 1.22M | |
| 30-May-23 7:01 PM View: | Stenhouse Mark Director | Phathom Pharmaceuticals, Inc. (PHAT) | 25-May-23 | Grant | 9,000 | -- | -- | 100% 0 to 9.0K | |
| 30-May-23 6:48 PM View: | Karbe Frank Director | Phathom Pharmaceuticals, Inc. (PHAT) | 25-May-23 | Grant | 9,000 | -- | -- | 100% 0 to 9.0K | |
| 30-May-23 6:55 PM View: | Parikh Asit Director | Phathom Pharmaceuticals, Inc. (PHAT) | 25-May-23 | Grant | 9,000 | -- | -- | 38% 23.5K to 32.5K | |
| 30-May-23 7:03 PM View: | Topper James N Director 10% Owner | Phathom Pharmaceuticals, Inc. (PHAT) | 25-May-23 | Grant | 9,000 | -- | -- | < 1% 5.84M to 5.85M | |
| 23-May-23 12:15 PM View: | Henderson Molly CFO and CBO | Phathom Pharmaceuticals, Inc. (PHAT) | 22-May-23 | Sale (Planned) | 2,110 | $12.87 | $27,165.00 | (3%) 72.92K to 70.81K | |
| 11-Apr-23 4:05 PM View: | Nabulsi Azmi Chief Operating Officer | Phathom Pharmaceuticals, Inc. (PHAT) | 11-Apr-23 | Private Purchase | 10,000 | $8.26 | $82,600.00 | 1% 877.62K to 887.62K | |
| 11-Apr-23 4:05 PM View: | Parikh Asit Director | Phathom Pharmaceuticals, Inc. (PHAT) | 10-Apr-23 | Private Purchase | 1,000 | $7.55 | $7,550.00 | 4% 22.5K to 23.5K | |
| 07-Apr-23 3:18 PM View: | Henderson Molly CFO and CBO | Phathom Pharmaceuticals, Inc. (PHAT) | 06-Apr-23 | Sale (Planned) | 3,439 | $7.27 | $25,001.50 | (5%) 76.35K to 72.92K | |
| 07-Apr-23 3:19 PM View: | Curran Terrie President and Chief Executive Director | Phathom Pharmaceuticals, Inc. (PHAT) | 06-Apr-23 | Private Purchase | 12,919 | $7.82 | $101,025.00 | 7% 177.61K to 190.53K | |
| 03-Mar-23 10:00 PM View: | Henderson Molly CFO and CBO | Phathom Pharmaceuticals, Inc. (PHAT) | 01-Mar-23 | Sale (Planned) | 2,032 | $8.53 | $17,334.80 | (3%) 78.39K to 76.35K | |
| 03-Mar-23 10:00 PM View: | Curran Terrie President and Chief Executive Director | Phathom Pharmaceuticals, Inc. (PHAT) | 01-Mar-23 | Sale (Planned) | 1,436 | $8.54 | $12,265.00 | (< 1%) 179.04K to 177.61K | |
| 14-Feb-23 4:56 PM View: | Parikh Asit Director | Phathom Pharmaceuticals, Inc. (PHAT) | 13-Feb-23 | Private Purchase | 5,000 | $7.73 | $38,660.00 | 29% 17.5K to 22.5K | |
| 20-Jan-23 7:39 PM View: | Curran Terrie President and Chief Executive Director | Phathom Pharmaceuticals, Inc. (PHAT) | 20-Jan-23 | Sale | 5,821 | $8.20 | $47,729.30 | (3%) 184.86K to 179.04K | |
| 20-Jan-23 7:32 PM View: | Henderson Molly CFO and CBO | Phathom Pharmaceuticals, Inc. (PHAT) | 19-Jan-23 | Grant | 33,000 | -- | -- | 73% 45.39K to 78.39K | |
| 20-Jan-23 7:35 PM View: | Nabulsi Azmi Chief Operating Officer | Phathom Pharmaceuticals, Inc. (PHAT) | 19-Jan-23 | Grant | 45,000 | -- | -- | 5% 832.62K to 877.62K | |
| 20-Jan-23 7:39 PM View: | Curran Terrie President and Chief Executive Director | Phathom Pharmaceuticals, Inc. (PHAT) | 19-Jan-23 | Grant | 97,500 | -- | -- | 112% 87.36K to 184.86K | |
| 12-Jan-23 4:32 PM View: | Parikh Asit Director | Phathom Pharmaceuticals, Inc. (PHAT) | 12-Jan-23 | Private Purchase | 5,000 | $7.00 | $35,000.00 | 40% 12.5K to 17.5K | |
| 23-Nov-22 4:07 PM View: | Curran Terrie President and Chief Executive Director | Phathom Pharmaceuticals, Inc. (PHAT) | 21-Nov-22 | Sale | 1,526 | $9.60 | $14,649.60 | (2%) 87.48K to 85.96K | |
| 23-Nov-22 4:10 PM View: | Henderson Molly CFO and CBO | Phathom Pharmaceuticals, Inc. (PHAT) | 21-Nov-22 | Sale | 2,159 | $9.60 | $20,726.40 | (5%) 45.84K to 43.68K | |
| 02-Sep-22 4:05 PM View: | Henderson Molly CFO and CBO | Phathom Pharmaceuticals, Inc. (PHAT) | 01-Sep-22 | Grant | 7,500 | -- | -- | 20% 38.34K to 45.84K | |
| 02-Sep-22 4:05 PM View: | Nabulsi Azmi Chief Operating Officer | Phathom Pharmaceuticals, Inc. (PHAT) | 01-Sep-22 | Grant | 7,500 | -- | -- | < 1% 822.53K to 830.03K | |
| 02-Sep-22 4:05 PM View: | Curran Terrie President and Chief Executive Director | Phathom Pharmaceuticals, Inc. (PHAT) | 01-Sep-22 | Grant | 7,500 | -- | -- | 9% 79.98K to 87.48K | |
| 20-May-22 5:17 PM View: | Henderson Molly CFO and CBO | Phathom Pharmaceuticals, Inc. (PHAT) | 19-May-22 | Grant | 12,000 | -- | -- | 46% 26.0K to 38.0K | |
| 20-May-22 5:19 PM View: | Nabulsi Azmi Chief Operating Officer | Phathom Pharmaceuticals, Inc. (PHAT) | 19-May-22 | Grant | 12,000 | -- | -- | 1% 807.92K to 819.92K | |
| 20-May-22 5:14 PM View: | Curran Terrie President and Chief Executive Director | Phathom Pharmaceuticals, Inc. (PHAT) | 19-May-22 | Grant | 12,000 | -- | -- | 18% 65.32K to 77.32K | |
| 16-May-22 8:48 PM View: | Nabulsi Azmi Chief Operating Officer | Phathom Pharmaceuticals, Inc. (PHAT) | 16-May-22 | Private Purchase | 20,000 | $8.16 | $163,288.00 | 3% 787.92K to 807.92K | |
| 16-May-22 8:43 PM View: | Henderson Molly CFO and CBO | Phathom Pharmaceuticals, Inc. (PHAT) | 13-May-22 | Purchase | 6,000 | -- | -- | 30% 20.0K to 26.0K | |
| 16-May-22 8:45 PM View: | Curran Terrie President and Chief Executive Director | Phathom Pharmaceuticals, Inc. (PHAT) | 13-May-22 | Private Purchase | 20,500 | $7.41 | $151,835.00 | 46% 44.82K to 65.32K | |
| 16-May-22 8:39 PM View: | Parikh Asit Director | Phathom Pharmaceuticals, Inc. (PHAT) | 12-May-22 | Private Purchase | 12,500 | $8.00 | $100,000.00 | 100% 0 to 12.5K | |
| 06-Apr-22 8:50 PM View: | Henderson Molly CFO and CBO | Phathom Pharmaceuticals, Inc. (PHAT) | 05-Apr-22 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K |
